Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial

Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of subjects who received NasoVAX at the specified dose in Study ALT-103-201, a study related to the safety and immunogenicity of NasoVAX in healthy adults.
    Difference
    0.2%
    Check dated 2024-06-06T14:26:30.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying both inclusion and exclusion criteria. Previously, this section had no information provided.
    Difference
    13%
    Check dated 2024-05-22T21:01:19.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:39:42.000Z thumbnail image

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.